25일 미국 증권거래위원회에 따르면 아이콘PLC의 자회사 중 다음과 같은 회사들이 ICON Investments Six Designated Activity Company의 5.809% Senior Secured Notes (2027년 만기), 5.849% Senior Secured Notes (2029년 만기), 6.000% Senior Secured Notes (2034년 만기)의 보증인으로 지정됐다.
아이콘의 자회사 이름은 다음과 같다: ICON Global Treasury Unlimited Company, ICON Clinical Research Limited, ICON Holdings Unlimited Company, ICON Clinical Research Property Development (Ireland) Limited, Accellacare Limited, ICON Operational Holdings Unlimited Company, ICON Operational Financing Unlimited Company, ICON Investments Four Unlimited Company, ICON Clinical Global Holdings Unlimited Company, ICON Luxembourg S.à r.l., ICON Early Phase Services, LLC, Beacon Bioscience, Inc., ICON Clinical Research LLC, ICON Laboratory Services, Inc., MolecularMD Corp., ICON US Holdings Inc., PriceSpective LLC, DOCS Global, Inc., Accellacare US Inc., Clinical Resource Network, LLC, ICON Clinical Investments LLC, PRA Health Sciences, Inc., ReSearch Pharmaceutical Services, Inc., Source Healthcare Analytics, LLC, Symphony Health Solutions Corporation, Pharmaceutical Research Associates, Inc., PRA Holdings, Inc., PRA International, LLC, RPS Global Holdings, LLC, RPS Parent Holding LLC, Roy RPS Holdings LLC, CRN Holdings, LLC.다.
또한, 다음의 자회사들의 모든 발행 및 유통 주식이 ICON Investments Six Designated Activity Company의 5.809% Senior Secured Notes (2027년 만기), 5.849% Senior Secured Notes (2029년 만기), 6.000% Senior Secured Notes (2034년 만기)를 담보하고 있다.
아이콘의 자회사 이름과 소유자, 담보 비율은 다음과 같다: ICON Investments Six Designated Activity Company (아일랜드) - ICON plc, 100%; ICON Clinical Research Limited (아일랜드) - ICON Operational Holdings Unlimited Company, 100%; ICON Holdings Unlimited Company (아일랜드) - ICON Operational Financing Unlimited Company, 100%; ICON Investments Four Unlimited Company (아일랜드) - ICON Clinical Global Holdings Unlimited Company, 100%; ICON Operational Holdings Unlimited Company (아일랜드) - ICON Operational Financing Unlimited Company, 100%; ICON Operational Financing Unlimited Company (아일랜드) - ICON Clinical Global Holdings Unlimited Company, 100%; ICON Clinical Global Holdings Unlimited Company (아일랜드) - ICON plc, 100%; ICON Investments Five Unlimited Company (아일랜드) - ICON plc, 100%; ICON Clinical Research Property Holdings (아일랜드) Limited (아일랜드) - ICON plc, 100%; ICON (LR) Limited (아일랜드) - ICON Clinical Research Limited, 100%; ICON Holdings Clinical Research International Limited (아일랜드) - ICON Holdings Unlimited Company, 100%; Accellacare Limited (아일랜드) - ICON Holdings Unlimited Company, 100%; ICON Global Treasury Unlimited Company (아일랜드) - ICON Clinical Research Limited, 100%; ICON Global Treasury Unlimited Company (아일랜드) - ICON plc, 100%; ICON Luxembourg S.à r.l. (룩셈부르크) - ICON Clinical Research Limited, 100%; ICON Early Phase Services, LLC (텍사스) - ICON Clinical Research LLC, 100%; Beacon Bioscience, Inc. (델라웨어) - ICON Clinical Research LLC, 100%; ICON Clinical Research LLC (델라웨어) - ICON US Holdings Inc., 100%; ICON Laboratory Services, Inc. (델라웨어) - ICON US Holdings Inc., 100%; MolecularMD Corp. (델라웨어) - ICON Laboratory Services, Inc., 100%; ICON US Holdings Inc. (델라웨어) - ICON Operational Financing Unlimited Company, 100%; PriceSpective LLC (델라웨어) - ICON Clinical Research LLC, 100%; CRN Holdings, LLC (델라웨어) - ICON Clinical Research LLC, 100%; ICON Clinical Investments, LLC (델라웨어) - ICON Luxembourg S.à r.l, 100%; Clinical Resource Network, LLC (일리노이) - CRN Holdings, LLC, 100%; DOCS Global, Inc. (뉴저지) - ICON Clinical Research LLC, 100%; Accellacare US Inc. (노스캐롤라이나) - ICON Clinical Research LLC, 100%; RPS Bermuda, Ltd. (버뮤다) - ReSearch Pharmaceutical Services, Inc., 65%; Services de Recherche Pharmaceutique Srl (캐나다) - ReSearch Pharmaceutical Services, Inc., 65%; PRA Health Sciences Colombia Ltda. (콜롬비아) - Pharmaceutical Research Associates, Inc., 65%; Pharmaceutical Research Associates Hungary Research and Development Ltd. (헝가리) - Pharmaceutical Research Associates, Inc., 65%; Pharmaceutical Research Associates Italy S.r.l. (이탈리아) - Pharmaceutical Research Associates, Inc., 65%; Pharmaceutical Research Associates Mexico S. de R.L. de C. V. (멕시코) - Pharmaceutical Research Associates, Inc., 65%; Pharmaceutical Research Associates Mexico S. de R.L. de C. V. (멕시코) - PRA International, LLC, 65%; ReSearch Pharmaceutical Services Netherlands B.V. (네덜란드) - ReSearch Pharmaceutical Services, Inc., 65%; RPS Perù S.A.C. (페루) - Pharmaceutical Research Associates, Inc., 65%; Research Pharmaceutical Services Puerto Rico, Inc. (푸에르토리코) - ReSearch Pharmaceutical Services, Inc., 65%; Pharmaceutical Research Associates Romania S.R.L. (루마니아) - Pharmaceutical Research Associates, Inc., 65%; Pharmaceutical Research Associates Espaňa, S.A.U. (스페인) - Pharmaceutical Research Associates, Inc., 65%; PRA International Sweden AB (스웨덴) - Pharmaceutical Research Associates, Inc., 65%; RPS Research (태국) Co., Ltd. (태국) - ReSearch Pharmaceutical Services, Inc., 65%; Sterling Synergy Systems Limited (영국) - Pharmaceutical Research Associates, Inc., 65%; ClinStar LLC (캘리포니아) - Pharmaceutical Research Associates, Inc., 100%; Nextrials, Inc. (캘리포니아) - Pharmaceutical Research Associates, Inc., 100%; Care Innovations, Inc. (델라웨어) - Pharmaceutical Research Associates, Inc., 100%; CRI NewCo, Inc. (델라웨어) - Pharmaceutical Research Associates, Inc., 100%; International Medical Technical Consultants, LLC (델라웨어) - Pharmaceutical Research Associates, Inc., 100%; Parallel 6, Inc. (델라웨어) - Pharmaceutical Research Associates, Inc., 100%; PRA Early Development Research, Inc. (델라웨어) - Pharmaceutical Research Associates, Inc., 100%; PRA Health Sciences, Inc. (델라웨어) - ICON US Holdings Inc., 100%; PRA Holdings, Inc. (델라웨어) - PRA Health Sciences, Inc., 100%; PRA Receivables, LLC (델라웨어) - Pharmaceutical Research Associates, Inc., 100%; ReSearch Pharmaceutical Services, Inc. (델라웨어) - Roy RPS Holdings, LLC, 100%; ReSearch Pharmaceutical Services, LLC (델라웨어) - ReSearch Pharmaceutical Services, Inc., 100%; Source Healthcare Analytics, LLC (델라웨어) - Symphony Health Solutions Corporation, 100%; Sunset Hills, LLC (델라웨어) - Pharmaceutical Research Associates, Inc., 100%; Symphony Health Solutions Corporation (델라웨어) - Pharmaceutical Research Associates, Inc., 100%; Pharmaceutical Research Associates, Inc. (버지니아) - PRA International, LLC, 100%; PRA International, LLC (델라웨어) - PRA Holdings, Inc., 100%; Roy RPS Holdings LLC (델라웨어) - RPS Parent Holding LLC, 100%; RPS Global Holdings, LLC (델라웨어) - PRA Holdings, Inc., 100%; RPS Parent Holding LLC (델라웨어) - RPS Global Holdings, LLC, 100%.다.
※ 본 컨텐츠는 AI API를 이용하여 요약한 내용으로 수치나 문맥상 요약이 컨텐츠 원문과 다를 수 있습니다. 해당 컨텐츠는 투자 참고용이며 투자를 할때는 컨텐츠 원문을 필히 필독하시기 바랍니다. 원문URL(https://www.sec.gov/Archives/edgar/data/1060955/000106095524000090/0001060955-24-000090-index.htm)
데이터투자 공시팀 pr@datatooza.com
